Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
Metabolic and Neurological Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
3 other identifiers
interventional
19
1 country
1
Brief Summary
As more adolescents with type 1 diabetes (T1D) opt to follow very low carbohydrate diets to improve glucose control, it is becoming increasingly important to study the metabolic and neurological changes that occur on these diets and how these effect patient safety. Understanding the impact of dietary changes on metabolic and neurological factors will help guide clinical advice about the overall safety and efficacy of these diets in the pediatric T1D population. This work will be the basis of future studies testing dietary interventions to improve glycemic control and ensure that these dietary interventions are safe for growing youth with T1D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 9, 2021
CompletedStudy Start
First participant enrolled
July 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 6, 2024
CompletedResults Posted
Study results publicly available
October 16, 2025
CompletedOctober 16, 2025
September 1, 2025
3 years
July 1, 2021
August 27, 2025
September 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Percent Time in the Optimal Glucose Range
Time in the optimal glucose range will be operationally defined as the percent time spent in the target range of 70-180 mg/dL during the 2 weeks.
2 weeks
Secondary Outcomes (2)
Percent Time Spent With Hypoglycemia.
2 weeks
Percent Time Spent With Hyperglycemia
2 weeks
Other Outcomes (1)
Human Factors
8 weeeks
Study Arms (2)
low carbohydrate diet
EXPERIMENTALIn this crossover study, participants will be randomized to either a low or standard carbohydrate for 2 weeks. Participants in the low carbohydrate group will limit carbohydrate intake to 15% of total daily calories.
standard carbohydrate diet
ACTIVE COMPARATORIn this crossover study, participants will be randomized to either a low or standard carbohydrate for 2 weeks. Participants in the standard carbohydrate group will follow an ad libitum diet with standard carbohydrate intake.
Interventions
Participants will engage in a diet that limits carbohydrate intake to 15% of total daily calories for 2 weeks.
Participants will engage in a diet that recommends standard carbohydrate intake with respect to total daily calories for 2 weeks.
Eligibility Criteria
You may qualify if:
- Diagnosis of type 1 diabetes for at least 1 year
- Hemoglobin A1c level \< 10% within the past 2 months
- Provision of signed and dated informed consent form by the adult (if person is at least 18 years old) or parent and assent form if the participant is \<18 years old.
- Stated willingness to comply with all study procedures and availability for the duration of the study
- All sexes are eligible
- Diagnosis of type 1 diabetes for at least 1 year
- Insulin pump use for at least 2 months.
- Ability to perform daily blood ketone checks, wear a continuous glucose monitor, willing to wear an activity monitor, willing to adhere to the study diets and keep a diet journal.
- For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional 4 weeks after the end of the dietary intervention.
- For males of reproductive potential: use of condoms or other methods to ensure effective contraception with partner
You may not qualify if:
- Current use of glucose-lowering agents other than insulin
- Unstable psychiatric disorders, including eating disorders
- Weight loss medications within the last 6 months
- Pregnancy or lactation, or planning pregnancy within the next 6 months
- BMI \< 19 kg/m2 for individuals 18 years of age or older
- BMI \< 5%ile for individuals under 18 years
- Weight less than 49 kg or 108 pounds
- Other medical conditions that may interfere with glucose metabolism and insulin sensitivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yale-New Haven Hospital
New Haven, Connecticut, 06511, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laura Nally
- Organization
- Yale school of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Laura M Nally, M.D.
Yale University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2021
First Posted
July 9, 2021
Study Start
July 29, 2021
Primary Completion
August 6, 2024
Study Completion
August 6, 2024
Last Updated
October 16, 2025
Results First Posted
October 16, 2025
Record last verified: 2025-09